Download the poster (JPG) · share it with colleagues and students
| Journal | International Journal of Applied Pharmaceutical Sciences (IJAPS), ISSN 2394-7446 (Online) |
| Special issue | Artificial Intelligence in Drug Discovery, Development and Regulatory Science |
| Access and licence | Open access · CC BY 4.0 · authors keep copyright |
| Peer review | Double-blind, at least two independent reviewers |
| DOI | Crossref DOI for every published article |
| Submission | Online at journal.ijapsonline.com |
| Manuscript deadline | 31 March 2027 |
Artificial intelligence (AI) is now used at every stage of the drug life cycle, and regulators are writing the rules for it. Machine learning supports target identification, molecular design, formulation optimisation, process control, clinical trial design and safety surveillance. The question has shifted from whether AI can help to whether its outputs are credible enough to support decisions on safety, efficacy and quality.
Regulators have started to answer that question:
Much of the published work is still computational proof-of-concept with little external validation. IJAPS especially welcomes studies that validate AI models against experimental or clinical data, compare them with conventional methods, or examine their regulatory and ethical readiness, including in low- and middle-income settings.
Submissions may address, but are not limited to, the six tracks below.
| Article type | What we look for |
|---|---|
| Original research | AI models validated against experimental, analytical or clinical data |
| Review / systematic review / meta-analysis | Critical synthesis with a clear method (PRISMA 2020 for systematic reviews) |
| Short communication | New tools, datasets or preliminary validated findings |
| Regulatory perspective / commentary | Analysis of guidance, policy gaps or comparative frameworks |
| Case study / tool report | Real-world use in industry, hospital, laboratory or classroom |
Length and format follow the IJAPS author guidelines.
| Milestone | Date |
|---|---|
| Call opens | 1 December 2026 |
| Optional abstract / intent to submit | 31 January 2027 |
| Full manuscript deadline | 31 March 2027 |
| First review decision | Within 4–6 weeks of submission |
| Final revised manuscripts | 31 May 2027 |
| Special issue complete | 30 June 2027 |
Accepted articles receive their DOI and are published online as soon as they are ready (continuous publication), then grouped in the special issue.
| Author category | APC (charged only after acceptance) |
|---|---|
| Indian authors | ₹5,000 |
| International authors | US$150 |
| Invited papers and selected high-quality submissions | Full waiver |
| Authors from low-income countries; students as first author | Waiver or discount on request |
There is no submission fee. Payment or waiver status has no influence on editorial decisions.
Questions about scope, waivers or pre-submission enquiries: Dr. K. Naga Raju, Editor-in-Chief · editor@ijapsonline.com